These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24361635)

  • 1. Anatomical specificity in the modulation of activity-regulated genes after acute or chronic lurasidone treatment.
    Luoni A; Rocha FF; Riva MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():94-101. PubMed ID: 24361635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated aripiprazole treatment regulates Bdnf, Arc and Npas4 expression under basal condition as well as after an acute swim stress in the rat brain.
    Luoni A; Fumagalli F; Racagni G; Riva MA
    Pharmacol Res; 2014 Feb; 80():1-8. PubMed ID: 24309096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid.
    Calabrese F; Luoni A; Guidotti G; Racagni G; Fumagalli F; Riva MA
    Psychopharmacology (Berl); 2013 Mar; 226(1):101-12. PubMed ID: 23093383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.
    Huang M; Horiguchi M; Felix AR; Meltzer HY
    Neuroreport; 2012 May; 23(7):436-40. PubMed ID: 22415605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress.
    Fumagalli F; Calabrese F; Luoni A; Bolis F; Racagni G; Riva MA
    Int J Neuropsychopharmacol; 2012 Mar; 15(2):235-46. PubMed ID: 21349227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone.
    Horisawa T; Nishikawa H; Toma S; Ikeda A; Horiguchi M; Ono M; Ishiyama T; Taiji M
    Behav Brain Res; 2013 May; 244():66-9. PubMed ID: 23376699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
    Ishibashi T; Horisawa T; Tokuda K; Ishiyama T; Ogasa M; Tagashira R; Matsumoto K; Nishikawa H; Ueda Y; Toma S; Oki H; Tanno N; Saji I; Ito A; Ohno Y; Nakamura M
    J Pharmacol Exp Ther; 2010 Jul; 334(1):171-81. PubMed ID: 20404009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lurasidone and fluoxetine reduce novelty-induced hypophagia and NMDA receptor subunit and PSD-95 expression in mouse brain.
    Stan TL; Sousa VC; Zhang X; Ono M; Svenningsson P
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1714-22. PubMed ID: 26256011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats.
    Luoni A; Hulsken S; Cazzaniga G; Racagni G; Homberg JR; Riva MA
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1319-30. PubMed ID: 23164505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed BDNF alterations in the prefrontal cortex of rats exposed to prenatal stress: preventive effect of lurasidone treatment during adolescence.
    Luoni A; Berry A; Calabrese F; Capoccia S; Bellisario V; Gass P; Cirulli F; Riva MA
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):986-95. PubMed ID: 24440552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
    Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY
    J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lurasidone on executive function in common marmosets.
    Murai T; Nakako T; Ikejiri M; Ishiyama T; Taiji M; Ikeda K
    Behav Brain Res; 2013 Jun; 246():125-31. PubMed ID: 23454675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of dopamine D4 receptor affinity contributes to the procognitive effect of lurasidone.
    Murai T; Nakako T; Ikeda K; Ikejiri M; Ishiyama T; Taiji M
    Behav Brain Res; 2014 Mar; 261():26-30. PubMed ID: 24304719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
    Ishiyama T; Tokuda K; Ishibashi T; Ito A; Toma S; Ohno Y
    Eur J Pharmacol; 2007 Oct; 572(2-3):160-70. PubMed ID: 17662268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dopamine D₂/D₃ and serotonin 5-HT₂A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography.
    Nakazawa S; Yokoyama C; Nishimura N; Horisawa T; Kawasaki A; Mizuma H; Doi H; Onoe H
    Psychopharmacology (Berl); 2013 Jan; 225(2):329-39. PubMed ID: 22868411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of withdrawal from repeated amphetamine exposure in peri-puberty on neuroplasticity-related genes in mice.
    Calabrese F; Richetto J; Racagni G; Feldon J; Meyer U; Riva MA
    Neuroscience; 2013 Oct; 250():222-31. PubMed ID: 23872394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia.
    Tarazi FI; Riva MA
    Expert Opin Drug Discov; 2013 Oct; 8(10):1297-307. PubMed ID: 23837554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment.
    de Bartolomeis A; Iasevoli F; Marmo F; Buonaguro EF; Eramo A; Rossi R; Avvisati L; Latte G; Tomasetti C
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):566-82. PubMed ID: 25649681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum.
    Chase T; Carrey N; Soo E; Wilkinson M
    Neuroscience; 2007 Feb; 144(3):969-84. PubMed ID: 17156936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.